Hydrogel nanoparticle based immunoassay
An immunoassay device incorporating porous polymeric capture nanoparticles within either the sample collection vessel or pre-impregnated into a porous substratum within fluid flow path of the analytical device is presented. This incorporation of capture particles within the immunoassay device improves sensitivity while removing the requirement for pre-processing of samples prior to loading the immunoassay device. A preferred embodiment is coreshell bait containing capture nanoparticles which perform three functions in one step, in solution: a) molecular size sieving, b) target analyte sequestration and concentration, and c) protection from degradation. The polymeric matrix of the capture particles may be made of co-polymeric materials having a structural monomer and an affinity monomer, the affinity monomer having properties that attract the analyte to the capture particle. This device is useful for point of care diagnostic assays for biomedical applications and as field deployable assays for environmental, pathogen and chemical or biological threat identification.
1. A method of analyte enrichment in an immunoassay, the method comprising:
providing an immunoassay device comprising a wicking matrix upstream of a porous matrix and an analyte binding region downstream of said porous matrix;
adding a sample fluid containing the analyte to porous hydrogel nanoparticles and allowing the analyte to sequester within the porous hydrogel nanoparticles, wherein said porous hydrogel nanoparticles i) range in size from 1 nm to 100 μm; ii) contain an analyte specific affinity bait internally within the particles for immobilization of the analyte; and iii) comprise an open polymeric meshwork that encloses the affinity bait;
allowing the sample fluid of to pass through the wicking matrix into the porous matrix; and
trapping the porous hydrogel nanoparticles into the porous matrix;
wherein the pore size of the porous matrix is such that the porous hydrogel nanoparticles do not migrate within the porous matrix and thereby the porous hydrogel nanoparticles are trapped at the entry point of the fluid to the porous matrix once the complete volume of sample fluid has passed from the wicking matrix to the porous matrix, enclosing therein the sequestered analyte for subsequent elution into the analyte binding region for immunoassay analysis of the analyte.